Personnel Moves Archives - Page 2 of 42

Integra LifeSciences CEO Jan De Witte to retire

Incoming Integra Lifesciences CEO Jan D. De Witte [Image courtesy of Integra]Integra LifeSciences (Nasdaq: IART) + announced today that President and CEO Jan De Witte informed the board of his intention to retire.

De Witte plans to retire following the appointment of a successor. Integra anticipates that appointment to come by the end of 2024. Additionally, the company appointed Stuart Essig, Integra chair, to the role of executive chair, effective immediately.As executive chair, Essig’s role entails driving shareholder value and ensuring an effective transition.

Essig became a non-executive chair in 2012 and previously served as Integra’s CEO from 1997 to 2012.

“We are grateful to Jan for his leadership and commitment to Integra and the role he has played in advancing our portfolio and building upon our legacy of innovation,” Essig said in a news release. “Jan’s personal decision to retire from Integra…

Osso VR picks new CEO as former leader transitions to new role

Osso VR announced today that it appointed Greg Born as its new CEO as Justin Barad transitions out of the role into a new position.

Born’s focus in the corner office centers around driving growth and expansion in the procedural training space. Osso VR develops academic programs with virtual reality (VR) training modules and simulations. Its platform, which features Osso Enterprise and Osso Academy, gives healthcare professionals ways to share, practice and learn new skills using hyper-realistic VR training.

The company offers modules in specialties including orthopedics, urology, cardiology, pediatrics and trauma. It also works with a number of leading medical device manufacturers worldwide. Earlier this month, it even launched a controller-free feature for its platforms.

Justin Barad founded the company and served as CEO for the past seven years. He intends to move into a chief strategy officer role to spearhead innovation efforts.

“A…

A high-ranking BD executive is set to retire

Dave Hickey. [Image from BD]BD (NYSE: BDX) + announced today that its EVP and President of Life Sciences, Dave Hickey, intends to retire this year.

Hickey plans for his retirement to go into effect on July 1, 2024. He originally joined BD in 2014, serving as president of Diagnostic Systems. He took over as president of Integrated Diagnostic Solutions in 2019 and began leading the Life Sciences segment in January 2021.

Prior to joining BD, Hickey held a range of executive leadership positions at Siemens Healthcare.

Read: Dave Hickey explains BD’s diagnostics business strategy.

“For over a decade at BD, Dave has demonstrated a strong, strategic and innovative approach, empowering his teams to deliver impactful results through a growth mindset and developing incredible talent and next-gen leaders at BD,” said Tom Polen, chair, CEO and president. “We wish him a…

Mitral valve repair company NeoChord has a new CEO

New NeoChord CEO Todd Berg. [Image from Metavention]NeoChord announced that it appointed Todd Berg as its new CEO to oversee its programs for mitral valve repair.

Minneapolis-based NeoChord develops technology for the delivery of artificial chords to treat mitral valve regurgitation. In the role, Berg oversees the clinical and commercial programs for the transeptal and transapical repair of damaged mitral valve chords.

The company’s DS1000 transapical (TA) chord repair system holds commercial marketing authorization in Europe. Its use spans the placement of more than 5,000 successful neochordae in more than 2,000 patients. The company’s NeXus transseptal (TS) chord repair system incorporates the same proprietary, suture-based anchor elements as DS1000. It’s currently in feasibility clinical trials.

Taking over the oversight of these products, Berg brings with him significant medtech experience over more than 30 years. He most recently serv…

The Bakken Medical Devices Center gets a new director

Hubert Lim, PhD, the incoming director of the Bakken Medical Devices Center at the University of Minnesota. [Image courtesy of BMDC]The Bakken Medical Devices Center at the University of Minnesota announced today that a longtime biomedical engineering professor will become its new director.

Hubert Lim, PhD, has been at the University of Minnesota for 14 years. He’s presently a professor in the Biomedical Engineering and Otolaryngology Departments at the university’s College of Science and Engineering.

In addition, Lim is active in the medtech startup community. He’s the chief scientific officer of Neuromod Devices (Dublin and Lisle, Illinois), which is developing a tinnitus treatment device) and chief scientific officer of SecondWave Systems (Minneapolis), which is developing a wearable ultrasound device for treating immune disorders.

Initially established in 2007 and located in the Mayo Building on the University of Minnesota Twin Cities …

QuidelOrtho terminates CEO

QuidelOrtho’s interim CEO Michael Iskra (left) and interim president Robert Bujarsku (right). [Image courtesy of QuidelOrtho]QuidelOrtho announced today that it terminated President and CEO Douglas Bryant, effective immediately.

The company said the decision came after a “comprehensive evaluation.” Bryant also resigned from the board of directors, effective today.

QuidelOrtho’s board formed the Office of the Chief Executive Officer on February 17 to ensure business continuity and effective leadership. The Office of the CEO is led by EVP and Chief Commercial Officer Michael Iskra, EVP and Chief Operating Officer Robert Bujarski and CFO Joseph Busky.

Iskra was appointed interim CEO and Bujarski interim president, both effective today. The pair will continue to fulfill their current responsibilities while assuming additional duties in their interim roles.

“Now is the time for a change in leadership that can accelerate our initiat…

A Medtronic EVP is leaving amid latest reorganization

Bob White [Image courtesy of Medtronic]Bob White, the EVP and president of Medtronic’s Medical Surgical portfolio, will be leaving the company due to a new round of reorganization.

CEO Geoff Martha announced that White was leaving at the end of the company’s Q3 earnings call this morning. Martha explained plans to end Medtronic’s ventilator business and combine what remains of Patient Monitoring and Respiratory Interventions into one business unit called Acute Care and Monitoring (ACM).

“He’s been such an impactful and important leader for the company for a long time, Martha said of White. “While the friendship will remain strong, we’re definitely going to miss working with him day to day. I want to wish him well. And know this comes from the board of directors and the executive committee and everybody at Medtronic who’s interacted with Bob — just a high ethical leader and just a good guy, and we wish him well.”…

CMR Surgical picks J&J veteran to lead efforts in Asia, Middle East, Africa

New CMR Surgical President and CCO for Asia Pacific, the Middle East and Africa, Sushobhan Dasgupta. [Image from Sushobhan Dasgupta on LinkedIn]CMR Surgical announced that it appointed Sushobhan Dasgupta as president and CCO for Asia Pacific, the Middle East and Africa.

Dasgupta offers more than 30 years of experience across diverse medtech markets globally. Notably, he spent three decades with Johnson & Johnson MedTech. Now, the veteran of the industry — and the region — comes to CMR to help drive operations around its surgical robot in the region.

Most recently, Dasgupta served as vice chair and global president at Shalby Limited, a healthcare group in India. There, he had responsibility for driving Shalby’s acquired orthopedic implant business, based in California. He also provided strategic oversight to the company’s base hospital business.

Dasgupta’s 30-year tenure at J&J MedTech included stints as a member of the J&J Orth…

High-ranking official in FDA’s CDRH plans to retire

Dr. William Maisel plans to retire this spring. [Image from the FDA website]Dr. William Maisel, Director of the Office of Product Evaluation and Quality (OPEQ) for the FDA Center for Devices and Radiological Health (CDRH) plans to retire this year.

MedTech Dive first reported the news on Feb. 15. An FDA spokesperson confirmed Maisel’s planned retirement via email. He spent more than 14 years with CDRH, including more than five years as director of OPEQ.

According to the spokesperson, Maisel plans to retire in the spring. CDRH plans to conduct a national search to fill his position.

In the interim, the FDA plans for Dr. Owen Faris to serve in an acting capacity as director of OPEQ. Faris currently serves as principal deputy director of Opeq and has spent more than two decades at the FDA. His previous roles include director of the Office of Clinical Evidence and Analysis and the clinical trials director, in addition to his current role in OPEQ.

O…

Medtronic names first chief sustainability officer

New Medtronic Chief Sustainability Officer Raman Venkatesh brings experience in sustainability efforts to the medtech giant. [Image courtesy of Ken Washington on LinkedIn]A Medtronic (NYSE: MDT) + executive shared on social media that the company named a chief sustainability officer.

Raman Venkatesh will join the medtech giant as VP and CSO — a newly created role — starting on Feb. 19. Ken Washington, Medtronic SVP and chief technology officer, announced the appointment on LinkedIn.

In the role, Venkatesh holds responsibility for leading the development and execution of the company’s environmental sustainability strategy.

“I am excited to see Raman and his team drive Medtronic forward on our sustainability journey,” Washington posted. “I am confident that together we will shape and unlock new innovative solutions that serve our patients and our planet.

Venkatesh’s career history…

Accelus adds duo of directors to its board

Bernie Haffey (left) and Kevin McGann (right). [Images courtesy of Accelus]Spine implant developer Accelus announced today that it appointed Kevin McGann and Bernie Haffey to its board of directors.

The Palm Beach Gardens, Florida-based company said the new appointments provide a strategic enhancement and align with its mission. Accelus aims to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes. It raised $20 million to support that expandable spine implant technology just last month.

McGann currently serves as president and CEO at Accelus, a role he first took up in April 2023. He originally joined the company in 2019 and served in roles including the post of chief commercial officer. McGann brings extensive experience in the spine industry, with previous positions including the role of VP of sales at Stryker.

Additionally, McGann served as VP of U.S. sales for Medtronic Spine & Biologics and area dire…

Enable Injections promotes COO from within

David Kroekel. [Image courtesy of Enable Injections]Wearable drug delivery technology maker Enable Injections announced today that it named David Kroekel as its new COO.

Cincinnati-based Enable develops the enFuse platform, whichallows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use. The FDA cleared the system for the delivery of Empaveli in October.

Get the full story at our sister site, Drug Delivery Business News.